文献速递瓣膜病与结构性心脏病

复发性感染性心内膜炎的当代流行病学与结局

Contemporary epidemiology and outcomes in recurrent infective endocarditis.
PubMed 文献 · Heart · 2019-10-03

该研究前瞻性纳入西班牙三家三级中心1996–2015年1335例感染性心内膜炎(IE)发作,复发IE占8.1%。复发分为再感染(不同微生物)和复发(6个月内同种微生物)。静脉药瘾者(IVDU)是再感染的独立预测因子(HR 3.92),人工瓣膜心内膜炎(PVE)和金黄色葡萄球菌是复发的独立预测因子;住院及3年死亡率与单次发作相当。

要点

  • 复发IE占8.1%,再感染与IVDU独立相关(HR 3.92)。
  • PVE和金黄色葡萄球菌感染增加复发风险(HR 3.19和3.14)。
  • 复发IE的住院及3年全因死亡率与单次发作无显著差异。

核心结论

  • 复发性IE仍是常见的晚期并发症,IVDU使再感染风险增加约四倍,PVE和金黄色葡萄球菌感染增加复发风险,但住院及长期死亡率与单次发作相当。

研究设计与样本

  • 前瞻性队列研究,1996–2015年西班牙三家三级中心连续纳入1335例IE发作,分为首次发作组(n=1227)和复发IE组(n=108,占8.1%),复发组再分为再感染(n=87)和复发(n=15)。

主要发现

  • 复发累积负担和发生率在第二个十年(2006–2015)略低(7.17 vs 4.10 events/100 survivors;7.51% vs 3.82%)。
  • 再感染患者较首次发作组更年轻、HIV感染更常见、IVDU和人工瓣膜携带者更多,栓塞并发症和心脏手术较少,住院死亡率相似。
  • IVDU是再感染的独立预测因子(HR 3.92,95% CI 1.86–8.28)。
  • 复发IE组中PVE和瓣周并发症更常见;药物治疗患者中PVE复发率更高(4.82% vs 0.43%,p=0.018)。
  • 金黄色葡萄球菌(HR 3.14,95% CI 1.11–8.86)和PVE(HR 3.19,95% CI 1.13–9.00)是复发的独立预测因子,住院死亡率与首次发作组相似。

临床怎么用

  • 对IVDU患者应警惕再感染风险,对PVE和金黄色葡萄球菌感染患者应警惕复发风险,需加强随访和预防策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recurrent infective endocarditis (IE) is a major complication of patients surviving a first episode of IE. This study sought to analyse the current state of recurrent IE in a large contemporary cohort. METHODS: 1335 consecutive episodes of IE were recruited prospectively in three tertiary care centres in Spain between 1996 and 2015. Episodes were categorised into group I (n=1227), first-IE episode and group II (n=108), recurrent IE (8.1%). After excluding six patients, due to lack of relevant data, group II was subdivided into IIa (n=87), reinfection (different microorganism), and IIb (n=15), relapse (same microorganism within 6 months of the initial episode). RESULTS: The cumulative burden and incidence of recurrence was slightly lower in the second decade of the study (2006-2015) (7.17 vs 4.10 events/100 survivors and 7.51% vs 3.82, respectively). Patients with reinfections, compared with group I, were significantly younger, had a higher frequency of HIV infection, were more commonly intravenous drug users (IVDU) and prosthetic valve carriers, had less embolic complications and cardiac surgery, with similar in-hospital mortality. IVDU was found to be an independent predictor of reinfection (HR 3.92, 95% CI 1.86 to 8.28).In the relapse IE group, prosthetic valve endocarditis (PVE) and periannular complications were more common. Among patients treated medically, those with PVE had a higher relapse incidence (4.82% vs 0.43% in native valve IE, p=0.018). Staphylococcus aureus and PVE were independent predictors of relapse (HR 3.14, 95% CI 1.11 to 8.86 and 3.19, 95% CI 1.13 to 9.00, respectively) and in-hospital-mortality was similar to group I. Three-year all-cause mortality was similar in recurrent episodes compared with single episodes. CONCLUSION: Recurrent IE remains a frequent late complication. IVDU was associated with a fourfold increase in the risk of reinfection. PVE treated medically and infections caused by S. aureus increased the risk of relapse. In-hospital and long-term mortality was comparable among groups.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Freitas-Ferraz AB, Tirado-Conte G, Vilacosta I, et al. Contemporary epidemiology and outcomes in recurrent infective endocarditis. Heart. 2019. PMID: 31582567. doi:10.1136/heartjnl-2019-315433

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。